Wolverine Trading’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $28.5M | Buy |
303,800
+57,900
| +24% | +$5.32M | 0.02% | 480 |
|
|
2025
Q2 | $21.2M | Buy |
245,900
+42,800
| +21% | +$3.63M | 0.02% | 457 |
|
|
2025
Q1 | $17.8M | Buy |
203,100
+50,600
| +33% | +$4.53M | 0.02% | 445 |
|
|
2024
Q4 | $12.1M | Sell |
152,500
-47,900
| -24% | -$4.15M | 0.01% | 690 |
|
|
2024
Q3 | $17.9M | Buy |
200,400
+58,400
| +41% | +$4.91M | 0.02% | 473 |
|
|
2024
Q2 | $11.2M | Sell |
142,000
-18,200
| -11% | -$1.49M | 0.01% | 597 |
|
|
2024
Q1 | $14M | Sell |
160,200
-60,000
| -27% | -$5.12M | 0.01% | 520 |
|
|
2023
Q4 | $18.1M | Sell |
220,200
-14,100
| -6% | -$1.07M | 0.02% | 485 |
|
|
2023
Q3 | $18.4M | Buy |
234,300
+68,900
| +42% | +$5.77M | 0.02% | 405 |
|
|
2023
Q2 | $14.4M | Sell |
165,400
-69,300
| -30% | -$5.97M | 0.02% | 459 |
|
|
2023
Q1 | $18.6M | Sell |
234,700
-131,000
| -36% | -$10.7M | 0.03% | 364 |
|
|
2022
Q4 | $28.4M | Buy |
365,700
+123,000
| +51% | +$9.97M | 0.04% | 325 |
|
|
2022
Q3 | $20M | Buy |
242,700
+25,700
| +12% | +$2.31M | 0.03% | 325 |
|
|
2022
Q2 | $19.6M | Buy |
217,000
+60,100
| +38% | +$6.09M | 0.03% | 310 |
|
|
2022
Q1 | $17.5M | Sell |
156,900
-8,900
| -5% | -$940K | 0.02% | 474 |
|
|
2021
Q4 | $17.3M | Hold |
165,800
| – | – | 0.02% | 510 |
|
|
2021
Q3 | $21M | Buy |
165,800
+55,700
| +51% | +$7.21M | 0.02% | 510 |
|
|
2021
Q2 | $13.7M | Buy |
110,100
+15,100
| +16% | +$1.9M | 0.02% | 558 |
|
|
2021
Q1 | $11.3M | Sell |
95,000
-19,000
| -17% | -$2.23M | 0.02% | 629 |
|
|
2020
Q4 | $13.2M | Sell |
114,000
-85,700
| -43% | -$9.43M | 0.02% | 553 |
|
|
2020
Q3 | $20.5M | Buy |
199,700
+31,700
| +19% | +$3.18M | 0.05% | 289 |
|
|
2020
Q2 | $15.2M | Sell |
168,000
-28,900
| -15% | -$2.77M | 0.04% | 330 |
|
|
2020
Q1 | $18.1M | Buy |
196,900
+83,600
| +74% | +$8.89M | 0.05% | 247 |
|
|
2019
Q4 | $12.8M | Sell |
113,300
-123,900
| -52% | -$13.6M | 0.03% | 561 |
|
|
2019
Q3 | $25.5M | Buy |
237,200
+17,700
| +8% | +$1.85M | 0.07% | 214 |
|
|
2019
Q2 | $21.4M | Buy |
219,500
+106,300
| +94% | +$9.71M | 0.06% | 268 |
|
|
2019
Q1 | $10.3M | Sell |
113,200
-44,100
| -28% | -$3.95M | 0.03% | 485 |
|
|
2018
Q4 | $14M | Buy |
157,300
+37,900
| +32% | +$3.54M | 0.04% | 349 |
|
|
2018
Q3 | $11.7M | Sell |
119,400
-42,100
| -26% | -$3.89M | 0.03% | 490 |
|
|
2018
Q2 | $13M | Hold |
161,500
| – | – | 0.03% | 391 |
|
|
2018
Q1 | $13M | Buy |
161,500
+10,900
| +7% | +$899K | 0.03% | 391 |
|
|
2017
Q4 | $12.2M | Sell |
150,600
-500
| -0.3% | -$40K | 0.04% | 421 |
|
|
2017
Q3 | $11.8M | Sell |
151,100
-83,100
| -35% | -$6.9M | 0.04% | 374 |
|
|
2017
Q2 | $20.8M | Buy |
234,200
+64,600
| +38% | +$5.45M | 0.1% | 191 |
|
|
2017
Q1 | $13.7M | Sell |
169,600
-31,900
| -16% | -$2.49M | 0.08% | 272 |
|
|
2016
Q4 | $14.4M | Buy |
201,500
+24,900
| +14% | +$1.96M | 0.07% | 287 |
|
|
2016
Q3 | $15.1M | Sell |
176,600
-16,700
| -9% | -$1.46M | 0.07% | 312 |
|
|
2016
Q2 | $16.5M | Buy |
+193,300
| New | +$15.6M | 0.09% | 207 |
|
Other funds holding MDT
Wolverine Trading's MDT Position: Q3 2025 in Review
Wolverine Trading reduced its Medtronic (MDT) stake by 61% in Q3 2025, selling an estimated $1.69M and leaving 11,650 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2804.
Wolverine Trading first reported a position in MDT in Q4 2016 and has held it in 32 quarters since. The position peaked at $14.1M in Q4 2019. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.
- Wolverine Trading held 11,650 shares of Medtronic worth $1.09M as of Q3 2025.
- Wolverine Trading sold 18,424 Medtronic shares in Q3 2025, an estimated $1.69M.
- Medtronic made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #2804 holding.
- Wolverine Trading first reported a position in Medtronic in Q4 2016 and has held it in 32 quarters since.
- Wolverine Trading's Medtronic position peaked at $14.1M in Q4 2019.
- 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.
Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.